SCS Capital Management
AGIO icon

SCS Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

SCS Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.4M Hold
612,850
– – 0.18% 68
2026
Q2 		$22.7M Hold
612,850
– – 0.21% 66
2026
Q1 		$20.7M Buy
612,850
+14,085
+2% +$399K 0.22% 61
2025
Q4 		$16.3M Hold
598,765
– – 0.17% 78
2025
Q3 		$24M Sell
598,765
-5,320
-0.9% -$200K 0.26% 60
2025
Q2 		$20.1M Sell
604,085
-7,013
-1% -$213K 0.22% 63
2025
Q1 		$17.9M Buy
+611,098
New +$20.3M 0.23% 59

Other funds holding AGIO

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

SCS Capital Management's AGIO Position: Q3 2026 in Review

SCS Capital Management held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 612,850 shares worth $20.4M. The position accounts for 0.18% of the portfolio, ranked #68.

SCS Capital Management first reported a position in AGIO in Q1 2025 and has held it in 7 quarters since. The position peaked at $24M in Q3 2025. 138 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • SCS Capital Management held 612,850 shares of Agios Pharmaceuticals worth $20.4M as of Q3 2026.
  • SCS Capital Management left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up 0.18% of SCS Capital Management's portfolio in Q3 2026, its #68 holding.
  • SCS Capital Management first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • SCS Capital Management's Agios Pharmaceuticals position peaked at $24M in Q3 2025.
  • 138 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on SCS Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.